-
EP3105213
European procedure
Extract from the Register of European Patents
EP About this file: EP3105213
| EP3105213 - DIHYDROBENZOFURAN COMPOUNDS USEFUL IN THE TREATMENT OF DIABETES AND OBESITY [Right-click to bookmark this link] | |||
| Former [2016/51] | FUSED HETEROCYCLIC COMPOUND | ||
| [2018/32] | Status | No opposition filed within time limit Status updated on 15.11.2019 Database last updated on 04.11.2024 | |
| Former | The patent has been granted Status updated on 07.12.2018 | ||
| Former | Grant of patent is intended Status updated on 22.07.2018 | ||
| Former | Examination is in progress Status updated on 08.09.2017 | ||
| Former | Request for examination was made Status updated on 18.11.2016 | Most recent event Tooltip | 15.11.2019 | No opposition filed within time limit | published on 18.12.2019 [2019/51] | Applicant(s) | For all designated states Takeda Pharmaceutical Company Limited 1-1, Doshomachi 4-chome Chuo-ku Osaka-shi Osaka 541-0045 / JP | [2016/51] | Inventor(s) | 01 /
SASAKI, Minoru c/o TAKEDA PHARMACEUTICAL COMPANY LIMITED 26-1, Muraoka-Higashi 2-chome Fujisawa-shi, Kanagawa 251-0012 / JP | 02 /
KAKEGAWA, Keiko c/o TAKEDA PHARMACEUTICAL COMPANY LIMITED 26-1, Muraoka-Higashi 2-chome Fujisawa-shi, Kanagawa 251-0012 / JP | 03 /
KIKUCHI, Fumiaki c/o TAKEDA PHARMACEUTICAL COMPANY LIMITED 26-1 Muraoka-Higashi 2-chome Fujisawa-shi, Kanagawa 251-0012 / JP | 04 /
IKEDA, Zenichi c/o TAKEDA PHARMACEUTICAL COMPANY LIMITED 26-1, Muraoka-Higashi 2-chome Fujisawa-shi, Kanagawa 251-0012 / JP | 05 /
NISHIKAWA, Yoichi c/o TAKEDA PHARMACEUTICAL COMPANY LIMITED 26-1, Muraoka-Higashi 2-chome Fujisawa-shi, Kanagawa 251-0012 / JP | [2016/51] | Representative(s) | Jones, Nicholas Andrew Withers & Rogers LLP 2 London Bridge London SE1 9RA / GB | [N/P] |
| Former [2016/51] | Jones, Nicholas Andrew Withers & Rogers LLP 4 More London Riverside London, SE1 2AU / GB | Application number, filing date | 15706546.7 | 12.02.2015 | [2016/51] | WO2015JP00639 | Priority number, date | JP20140025832 | 13.02.2014 Original published format: JP 2014025832 | [2016/51] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2015122187 | Date: | 20.08.2015 | Language: | EN | [2015/33] | Type: | A1 Application with search report | No.: | EP3105213 | Date: | 21.12.2016 | Language: | EN | The application published by WIPO in one of the EPO official languages on 20.08.2015 takes the place of the publication of the European patent application. | [2016/51] | Type: | B1 Patent specification | No.: | EP3105213 | Date: | 09.01.2019 | Language: | EN | [2019/02] | Search report(s) | International search report - published on: | EP | 20.08.2015 | Classification | IPC: | C07D307/81, A61K31/343, A61P3/00 | [2016/51] | CPC: |
C07D307/81 (EP,EA,KR,US);
C07D307/79 (CN);
A61K31/343 (KR);
A61P1/02 (EP);
A61P1/04 (EP);
A61P1/12 (EP);
A61P1/16 (EP);
A61P1/18 (EP);
A61P11/00 (EP);
A61P13/10 (EP);
A61P13/12 (EP);
A61P15/08 (EP);
A61P19/02 (EP);
A61P19/06 (EP);
A61P19/10 (EP);
A61P21/00 (EP);
A61P21/04 (EP);
A61P25/16 (EP);
A61P25/22 (EP);
A61P25/28 (EP);
A61P29/00 (EP);
A61P3/00 (EP);
A61P3/04 (EP);
A61P3/06 (EP);
A61P3/08 (EP);
A61P3/10 (EP);
A61P35/00 (EP);
A61P35/02 (EP);
A61P43/00 (EP);
A61P5/50 (EP);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2016/51] | Extension states | BA | 10.08.2016 | ME | 10.08.2016 | Title | German: | DIHYDROBENZOFURANVERBINDUNGEN ZUR BEHANDLUNG VON DIABETES UND ADIPOSITAS | [2018/32] | English: | DIHYDROBENZOFURAN COMPOUNDS USEFUL IN THE TREATMENT OF DIABETES AND OBESITY | [2018/32] | French: | COMPOSÉS DIHYDROBENZOFURANIQUES UTILES POUR TRAITER LE DIABÈTE ET L'OBÉSITÉ | [2018/32] |
| Former [2016/51] | KONDENSIERTE HETEROCYCLISCHE VERBINDUNG | ||
| Former [2016/51] | FUSED HETEROCYCLIC COMPOUND | ||
| Former [2016/51] | COMPOSÉ HÉTÉROCYCLIQUE FUSIONNÉ | Entry into regional phase | 10.08.2016 | National basic fee paid | 10.08.2016 | Designation fee(s) paid | 10.08.2016 | Examination fee paid | Examination procedure | 10.08.2016 | Amendment by applicant (claims and/or description) | 10.08.2016 | Examination requested [2016/51] | 10.08.2016 | Date on which the examining division has become responsible | 06.09.2017 | Despatch of a communication from the examining division (Time limit: M06) | 11.03.2018 | Reply to a communication from the examining division | 03.04.2018 | Despatch of a communication from the examining division (Time limit: M04) | 26.06.2018 | Reply to a communication from the examining division | 23.07.2018 | Communication of intention to grant the patent | 27.11.2018 | Fee for grant paid | 27.11.2018 | Fee for publishing/printing paid | 27.11.2018 | Receipt of the translation of the claim(s) | Opposition(s) | 10.10.2019 | No opposition filed within time limit [2019/51] | Fees paid | Renewal fee | 08.02.2017 | Renewal fee patent year 03 | 14.02.2018 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]JPH03200764 (SNOW BRAND MILK PROD CO LTD) [A] 1-19 * compounds 1-6 *; | [A]US5116985 (TAKESHITA YASUYOSHI [JP], et al) [A] 1-19 * column 1, line 26 - column 2, line 18; claim 1; compounds 1-12 *; | [A]EP2511271 (AJINOMOTO KK [JP]) [A] 1-19 * compounds in the tables on page 65 to page 76;; claims 1, 13-15, 20 *; | [AD]WO2013039187 (ASTELLAS PHARMA INC [JP], et al) [AD] 1-19 * examples 4, 6-10, 21, 22, 28, 59, 71, 80, 97, 100-104, 106, 107, 112, 113, 116, 117, 119-121, 124-126;; claims 1, 11 *; | [IP]WO2014142219 (ASTELLAS PHARMA INC [JP]) [IP] 1-19* claims 1, 12; compound 10 *; | [A] - ZLATOIDSKY P ET AL, "Synthesis and structure-activity relationship study of the new set of trypsin-like proteinase inhibitors", EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, EDITIONS SCIENTIFIQUE ELSEVIER, PARIS, FR, (19991201), vol. 34, no. 12, doi:10.1016/S0223-5234(99)00123-3, ISSN 0223-5234, pages 1023 - 1034, XP004186871 [A] 1-19 * figure 1; compound 2k * DOI: http://dx.doi.org/10.1016/S0223-5234(99)00123-3 | by applicant | WO9710224 | WO0114372 | WO0206234 | WO2004039365 | WO2004041266 | WO2004048363 | WO2004106276 | WO2005030740 | WO2005058823 | WO2005063729 | WO2005063725 | WO2005087710 | WO2005095338 | WO2005113504 | WO2006112549 | WO2007013694 | WO2007013689 | WO2007018314 | WO2007028135 | WO2008001931 | WO2008047821 | WO2008050821 | WO2008093639 | WO2008099794 | WO2008136428 | WO2008156757 | WO2009071601 | WO2011071048 | WO2012169579 | WO2013039187 | WO2013187533 | - "Design of Molecules", IYAKUHIN no KAIHATSU (Development of Pharmaceuticals), HIROKAWA SHOTEN, (1990), vol. 7, pages 163 - 198 | - THE CHEMICAL SOCIETY OF JAPAN, Jikken Kagaku Koza (Encyclopedia of Experimental Chemistry in English), 5th Ed.,, vol. 13-19 | - THE CHEMICAL SOCIETY OF JAPAN, Shin Jikken Kagaku Koza (New Encyclopedia of Experimental Chemistry in English), vol. 14-15 | - L. F. TIETZE, TH. EICHER,, Reactions and Syntheses in the Organic Chemistry Laboratoryy, Revised, 2nd Ed., NANKODO CO., LTD. | - HIDEO TOGO, Revised Organic Name Reactions; The Reaction Mechanism and Essence, KODANSHA LTD. | - ORGANIC SYNTHESES Collective, JOHN WILEY & SONS INC., vol. I-VII | - JIE JACK LI, Modem Organic Synthesis in the Laboratory A Collection of Standard Experimental Procedures, OXFORD UNIVERSITY PRESS | - Comprehensive Heterocyclic Chemistry III, ELSEVIER B.V., vol. 1-14 | - KIYOSHI TOMIOKA, Strategic Applications of Named Reactions in Organic Synthesis, KAGAKU-DOJIN PUBLISHING COMPANY, INC | - THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, (2001), vol. 285, pages 2486 - 2497 |